Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Shimada

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Disease|July 10, 2019
Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspirationEriko Kuwasaki, Tetsutaro Nagaoka, Hiroaki Ihara, et al.
BMC Cancer|March 12, 2016
Cerebral infarction in advanced non-small cell lung cancer: a case control studyMotoyasu Kato, Takehito Shukuya, Keita Mori, et al.
Thoracic Cancer|December 16, 2022
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancerKana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada, et al.
Neuroscience Letters|September 19, 2012
Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in miceSatoshi Okuyama, Naoko Shimada, Miki Kaji, et al.
Biochemical and Biophysical Research Communications|December 3, 2014
Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancerFariz Nurwidya, Fumiyuki Takahashi, Isao Kobayashi, et al.
BMC Cancer|March 26, 2022
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, et al.
BMC Cancer|July 12, 2014
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung diseaseMotoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi, et al.
Translational Lung Cancer Research|April 11, 2024
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case reportShiting Xu, Takehito Shukuya, Shoko Shimamura, et al.
Thoracic Cancer|September 4, 2024
Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferationYoshika Koinuma, Yoichiro Mitsuishi, Wira Winardi, et al.
Journal of Translational Medicine|February 28, 2021
High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational studyIssei Sumiyoshi, Takahiro Okabe, Shinsaku Togo, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Disease|July 10, 2019
Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspirationEriko Kuwasaki, Tetsutaro Nagaoka, Hiroaki Ihara, et al.
BMC Cancer|March 12, 2016
Cerebral infarction in advanced non-small cell lung cancer: a case control studyMotoyasu Kato, Takehito Shukuya, Keita Mori, et al.
Thoracic Cancer|December 16, 2022
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancerKana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada, et al.
Neuroscience Letters|September 19, 2012
Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in miceSatoshi Okuyama, Naoko Shimada, Miki Kaji, et al.
Biochemical and Biophysical Research Communications|December 3, 2014
Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancerFariz Nurwidya, Fumiyuki Takahashi, Isao Kobayashi, et al.
BMC Cancer|March 26, 2022
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, et al.
BMC Cancer|July 12, 2014
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung diseaseMotoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi, et al.
Translational Lung Cancer Research|April 11, 2024
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case reportShiting Xu, Takehito Shukuya, Shoko Shimamura, et al.
Thoracic Cancer|September 4, 2024
Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferationYoshika Koinuma, Yoichiro Mitsuishi, Wira Winardi, et al.
Journal of Translational Medicine|February 28, 2021
High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational studyIssei Sumiyoshi, Takahiro Okabe, Shinsaku Togo, et al.
Pageof 6